Search
Atopic Dermatitis Paid Clinical Trials in New Mexico
A listing of 2 Atopic Dermatitis clinical trials in New Mexico actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1 - 2 of 2
Match to Clinical Trials
Access to cutting-edge treatments
Latest clinical trials
Find trials in your area
Search by Name
Filter by Condition
Atopic Dermatitis
Filter by Age
Filter by Type
Gender
Type of Study
Clinical Trial Phase
The state of New Mexico currently has 2 active clinical trials seeking participants for Atopic Dermatitis research studies. These trials are conducted in various cities, including Albuquerque, Santa Fe, Las Cruces and Farmington.
Featured Trial
Paid Clinical Studies Nationwide
Recruiting
Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.
Featured Trial
Atopic Dermatitis Study
Recruiting
The BroADen Study is looking for adults 18–55 to join in on research for a once-daily oral study drug that
may help reduce the symptoms of atopic dermatitis (AD). This research is evaluating if the investigational
study drug is safe and how it works in adults with moderate to severe AD (eczema).
may help reduce the symptoms of atopic dermatitis (AD). This research is evaluating if the investigational
study drug is safe and how it works in adults with moderate to severe AD (eczema).
Conditions:
Atopic Dermatitis
Dermatitis
Atopic
Atopic Dermatitis Eczema
Moderate-to-Severe Atopic Dermatitis
Featured Offer
Lose Weight with GLP-1 Medications
Recruiting
Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.
As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.
Conditions:
Overweight
Overweight and Obesity
Obesity
Weight Loss
Morbid Obesity
A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)
Recruiting
The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.
Gender:
ALL
Ages:
Between 12 years and 100 years
Trial Updated:
07/24/2025
Locations: Albuquerque Clinical Trials Incorporated, Albuquerque, New Mexico
Conditions: Atopic Dermatitis
A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden
Recruiting
The purpose of this study is to measure how well taking lebrikizumab alone works for participants with fewer places on the body with eczema (atopic dermatitis), but these places may be very itchy.
Participation in this study will last up to approximately 38 weeks (9 and a half months) including 24 weeks (6 months) of treatment.
Gender:
ALL
Ages:
12 years and above
Trial Updated:
07/15/2025
Locations: Albuquerque Clinical Trials, Inc., Albuquerque, New Mexico
Conditions: Atopic Dermatitis
1 - 2 of 2